EditFrom NeuroLex
Resource:CATIE - Alzheimers Disease
| Name: | Resource:CATIE - Alzheimers Disease |
| Description: | Many people with Alzheimer's disease develop symptoms including delusions, agitation, aggressive behavior, or hallucinations. These symptoms add to the many difficulties of living with Alzheimer's disease. The CATIE Alzheimer's Disease Study aims to find out the most effective medication treatments for these symptoms, and to improve the quality of life of people with Alzheimer's disease, their families, and caregivers.
The last CATIE-AD patient completed the trial in October. Over the last few months, we have been working assiduously to lock the database and check the analysis programming. CATIE-AD is a trial that will provide layers of results. The complex outcomes will depend not only on randomized treatment assignment but the interactions of the clinical sites with the patients and caregivers. The main goals are to generate hypotheses about effectiveness and other issues with antipsychotic use that might undergo future testing. Dissemination of outcomes from CATIE-AD will be rolled out over the next 8 months at several meetings. (2005) Additional information may be found by following the links, http://www.nimh.nih.gov/trials/practical/catie/index.shtml, http://www.clinicaltrials.gov/ct2/show/NCT00015548?term=CATIE&rank=2 |
| Other Name(s): | CATIE - Alzheimer's Disease, CATIE-Alzheimer's Disease, CATIE Alzheimer's Disease Study, Clinical Antipsychotic Trials in Intervention Effectiveness Alzheimer's Disease, Clinical Antipsychotic Trials in Intervention Effectiveness Alzheimer's Disease Study, Clinical Antipsychotic Trials in Intervention Effectiveness - Alzheimer's Disease, Clinical Antipsychotic Trials in Intervention Effectiveness - AD |
| Parent Organization: | University of North Carolina at Chapel Hill; North Carolina; USA |
| Supporting Agency: | National Institute of Mental Health |
| Related to: | Resource:CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness, Resource:Clinicaltrials.gov: A Service Of The National Institutes Of Health |
| Resource Type(s): | Clinical trial |
| Keywords: | Alzheimer's disease, Clinical trial, Treatment, Outcome, Medicine, Late adult human, Antipsychotic drug |
| Abbreviation: | CATIE-AD, CATIE - AD |
| Resource: | Resource |
| URL: | http://www.catie.unc.edu/alzheimers/ |
| Related condition/disease: | Alzheimer's disease |
| Id: | nlx_146234 |
| Organism: | Human |
| Link to OWL / RDF: | Download this content as OWL/RDF |
Categories related to Resource:CATIE - Alzheimers Disease
Curation status: Curated
For Resource Owners:
A sitemap will keep your NIF Registry description up-to-date and inform search engines about your resource.
Please login to create the sitemap. (top right)
Learn more about what NIF can do for your resource.
Proudly proclaim your inclusion in NIF by displaying the "Registered with NIF" button on your site.
Notes
This page uses this default form:Resource
| Abbrev | CATIE-AD, CATIE - AD + |
| CurationStatus | curated + |
| DefiningCitation | http://www.catie.unc.edu/alzheimers/ + |
| Definition | Many people with Alzheimer's disease devel … Many people with Alzheimer's disease develop symptoms including delusions, agitation, aggressive behavior, or hallucinations. These symptoms add to the many difficulties of living with Alzheimer's disease. The CATIE Alzheimer's Disease Study aims to find out the most effective medication treatments for these symptoms, and to improve the quality of life of people with Alzheimer's disease, their families, and caregivers.
The last CATIE-AD patient completed the trial in October. Over the last few months, we have been working assiduously to lock the database and check the analysis programming. CATIE-AD is a trial that will provide layers of results. The complex outcomes will depend not only on randomized treatment assignment but the interactions of the clinical sites with the patients and caregivers. The main goals are to generate hypotheses about effectiveness and other issues with antipsychotic use that might undergo future testing. Dissemination of outcomes from CATIE-AD will be rolled out over the next 8 months at several meetings. (2005) Additional information may be found by following the links, http://www.nimh.nih.gov/trials/practical/catie/index.shtml, http://www.clinicaltrials.gov/ct2/show/NCT00015548?term=CATIE&rank=2 gov/ct2/show/NCT00015548?term=CATIE&rank=2 |
| ExampleImage |  + |
| Has default formThis property is a special property in this wiki. | Resource + |
| Has role | Clinical trial + |
| Id | nlx_146234 + |
| Is part of | University of North Carolina at Chapel Hill; North Carolina; USA + |
| Keywords | Alzheimer's disease +, Clinical trial +, Treatment +, Outcome +, Medicine +, Late adult human +, and Antipsychotic drug + |
| Label | Resource:CATIE - Alzheimers Disease + |
| ModifiedDate | 26 June 2012 + |
| Page has default formThis property is a special property in this wiki. | Resource + |
| RelatedTo | Resource:CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness +, and Resource:Clinicaltrials.gov: A Service Of The National Institutes Of Health + |
| Related disease | Alzheimer's disease + |
| Species | Human + |
| SuperCategory | Resource + |
| Supporting Agency | National Institute of Mental Health + |
| Synonym | CATIE - Alzheimer's Disease +, CATIE-Alzheimer's Disease +, CATIE Alzheimer's Disease Study +, Clinical Antipsychotic Trials in Intervention Effectiveness Alzheimer's Disease +, Clinical Antipsychotic Trials in Intervention Effectiveness Alzheimer's Disease Study +, Clinical Antipsychotic Trials in Intervention Effectiveness - Alzheimer's Disease +, and Clinical Antipsychotic Trials in Intervention Effectiveness - AD + |
